American Journal of Roentgenology, Vol 161, 1191-1198, Copyright © 1993 by American Roentgen Ray Society

ARTICLES

MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions

TC Winter 3d, PC Freeny, HV Nghiem, LA Mack, RM Patten, CR Thomas Jr and S Elliott
Department of Radiology, University of Washington Medical Center, Seattle 98195.

OBJECTIVE. The purpose of this study was to evaluate the efficacy of superparmagnetic iron oxide (SPIO) in the detection of focal hepatic lesions on MR images. SUBJECTS AND METHODS. The study included 21 patients with 115 focal hepatic lesions and eight patients without focal hepatic lesions. T1- and T2-weighted MR images were obtained at 1.5 T before and 60 min after the end of injection of an SPIO agent. Contrast-enhanced CT scans were obtained in all patients within 10 days after MR imaging. The effect of SPIO on the signal intensity of the liver and spleen was assessed by using quantitative analysis of the region of interest. Efficacy was evaluated by using multiple criteria and unenhanced and SPIO-enhanced images. Evaluations included subjective assessment of image quality, counting the number of lesions detected, and statistical analysis of quantitative changes in the signal intensity of lesions and of normal liver. RESULTS. By all criteria, SPIO-enhanced T2-weighted MR images were superior to unenhanced T2-weighted images and to contrast-enhanced CT scans. Conversely, by all criteria, SPIO-enhanced T1-weighted MR images were worse than unenhanced T1-weighted images and contrast-enhanced CT scans. The mean lesion-to-liver contrast on T2-weighted images was 317% on unenhanced images and 1745% on SPIO-enhanced images. For T1- weighted, the mean contrast was 26% on unenhanced images and 18% on SPIO-enhanced images. CONCLUSION. SPIO is an efficacious contrast agent for the detection of focal hepatic lesions when T2-weighted MR images are used.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Matsuo, M. Kanematsu, K. Itoh, T. Murakami, Y. Maetani, H. Kondo, S. Goshima, N. Kako, H. Hoshi, J. Konishi, et al. Detection of Malignant Hepatic Tumors with Ferumoxides-Enhanced MRI: Comparison of Five Gradient-Recalled Echo Sequences with Different TEs Am. J. Roentgenol., January 1, 2004; 182(1): 235 - 242. [Abstract] [Full Text] [PDF]

				S. K. Kim, S. H. Kim, W. J. Lee, H. Kim, J. W. Seo, D. Choi, H. K. Lim, S. J. Lee, and J. H. Lim Preoperative Detection of Hepatocellular Carcinoma: Ferumoxides-Enhanced Versus Mangafodipir Trisodium--Enhanced MR Imaging Am. J. Roentgenol., September 1, 2002; 179(3): 741 - 750. [Abstract] [Full Text] [PDF]

				S. S. Raman, D. S. K. Lu, S. C. Chen, J. Sayre, F. Eilber, and J. Economou Hepatic MR Imaging Using Ferumoxides: Prospective Evaluation with Surgical and Intraoperative Sonographic Confirmation in 25 Cases Am. J. Roentgenol., October 1, 2001; 177(4): 807 - 812. [Abstract] [Full Text] [PDF]

				D. Choi, S. H. Kim, J. H. Lim, W. J. Lee, H.-J. Jang, S. J. Lee, and H. K. Lim Preoperative Detection of Hepatocellular Carcinoma: Ferumoxides-Enhanced MR Imaging Versus Combined Helical CT During Arterial Portography and CT Hepatic Arteriography Am. J. Roentgenol., February 1, 2001; 176(2): 475 - 482. [Abstract] [Full Text] [PDF]

				D. A. Bluemke, E. K. Paulson, M. A. Choti, S. DeSena, and P. A. Clavien Detection of Hepatic Lesions in Candidates for Surgery: Comparison of Ferumoxides-Enhanced MR Imaging and Dual-Phase Helical CT Am. J. Roentgenol., December 1, 2000; 175(6): 1653 - 1658. [Abstract] [Full Text] [PDF]

				K. Mori, H. Yoshioka, Y. Itai, Y. Okamoto, H. Mori, N. Takahashi, and Y. Saida Arterioportal Shunts in Cirrhotic Patients: Evaluation of the Difference Between Tumorous and Nontumorous Arterioportal Shunts on MR Imaging with Superparamagnetic Iron Oxide Am. J. Roentgenol., December 1, 2000; 175(6): 1659 - 1664. [Abstract] [Full Text] [PDF]

				S. Hirohashi, K. Ueda, H. Uchida, W. Ono, J. Takahama, M. Takewa, S. Kitano, and H. Ohishi Nondiffuse Fatty Change of the Liver: Discerning Pseudotumor on MR Images Enhanced with Ferumoxides-Initial Observations Radiology, November 1, 2000; 217(2): 415 - 420. [Abstract] [Full Text]

				P. Reimer, N. Jähnke, M. Fiebich, W. Schima, F. Deckers, C. Marx, N. Holzknecht, and S. Saini Hepatic Lesion Detection and Characterization: Value of Nonenhanced MR Imaging, Superparamagnetic Iron Oxide-enhanced MR Imaging, and Spiral CT-ROC Analysis Radiology, October 1, 2000; 217(1): 152 - 158. [Abstract] [Full Text]

				J. Ward, F. Chen, J. A. Guthrie, D. Wilson, J. P. A. Lodge, J. I. Wyatt, and P. J. Robinson Hepatic Lesion Detection after Superparamagnetic Iron Oxide Enhancement: Comparison of Five T2-weighted Sequences at 1.0 T by Using Alternative-Free Response Receiver Operating Characteristic Analysis1 Radiology, January 1, 2000; 214(1): 159 - 166. [Abstract] [Full Text]